Annual Meeting & Pre-Conference Programs

Biomarkers Workshop

Cancer immune Responsiveness Workshop

Journal for Immunotherapy of Cancer

SITC Consensus Statements, Guidelines and White Papers

• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

• Upcoming Live Webinars
  • SITC Clinical Practice Guideline Webinar – Immune Checkpoint Inhibitor-related Adverse Events: August 13, 2021, 10 AM - 11 AM ET
  • SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events: September 16, 2021, 11:30 AM - 12:30 PM ET
  • SITC Clinical Practice Guideline Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events: October 6, 2021, 7 PM - 8 PM ET
• On-Demand Webinars
  • SITC Clinical Practice Guideline Webinar – Immune Effector Cell-related Adverse Events: View On-demand

• SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
• Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I—conceptual challenges
• Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
• Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
• Systematic evaluation of immune regulation and modulation
• Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

Textbook

Section 1: Basic Principles of Tumor Immunology

• Chapter 1: Introduction to Basic Sciences: Cracking the Code of Cancer Immune Responsiveness and the Evolution of Cancer Biology
• Chapter 13: Chemokines and Chemokine Receptors: Regulators of the Balance between Antitumor and Pro tumor Immunity and Promising Targets in Cancer Immunotherapy

Section 2: Cancer Immunotherapy Targets and Classes

• Chapter 22: Immune Effects of Conventional Cancer Therapeutics

Section 3: Immune Function in Cancer

• Chapter 27: Intratumoral Gene Signatures and Host Genetic Variations Associated with Immune Responsiveness

Online Courses

Webinars

• Acute Leukemia
• Cutaneous Melanoma
• Head and Neck Cancers
• Immune Effector Cell-related Adverse Events
• Lymphoma
• Multiple Myeloma
• Non-Small Cell Lung Cancer
• Renal Cell Carcinoma